|
An alarm issue was reported with the abbott diabetes care (adc) device in use with samsung s24, android operating system and version 16.The low glucose alarms did not sound and the customer was not alerted of changes in glucose level.The customer experienced symptoms described as "numb hands, shakiness of hands" and self-treated by consuming "juice, food, siripiri glucose tablets, and a candy".No third-party treatment was provided.There was no report of death or permanent impairment associated with this event.
|
|
An investigation has been performed for the reported complaint and there was no indication that the product did not meet specification.The customer experienced missing low glucose alarms with freestyle librelink application.Adc attempted to replicate the reported issue using similar configuration of samsung galaxy s22, android 16, 2.13.1.11596.The reported issue was unable to be replicated and the system functioned as intended.There were no issue identified with the freestyle librelink application during replication that would have led to the reported issue.The most probable root causes associated with this failure mode are software/data corruption or misuse.However, mitigations are in place to reduce and prevent such issues.All vital functions are monitored by the system and, when necessary, function is suspended to safeguard against inaccurate results.Labeling is provided to instruct the user on the intended use of all vital parts of the system to minimize misuse.All complaints and complaint trends are investigated to determine if there is a product defect/ deficiency.If a product defect/ deficiency is identified, a risk evaluation is completed and compared to the risk management report, to ensure the risk profile has not changed.Additionally, as a part of abbott¿s post-market surveillance process, all risk evaluations with associated complaint data are reviewed annually to determine if the risk profiles have changed as compared to the product risk management reports.These monitoring processes ensure that all product risk profiles remain acceptable and have a positive benefit/ risk ratio.Section d.Suspected medical device and g4 - pma/510(k)# has been populated for the freestyle librelink android application as this report concerns a finland customer.This is same/similar to us freestyle libre 2 android application, model number 71857-01.All pertinent information available to abbott diabetes care has been submitted.
|